A group of lawyers in China have drafted an open letter calling for more legislation to ensure vaccine safety.
The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.
For the first time, the public health watchdogs at the Access to Medicine Foundation have trained their microscopes specifically on vaccines and the…
Novavax isn’t letting a bruising phase 3 failure for its RSV vaccine kill its enthusiasm around the program.
Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.
Inovio’s Zika and MERS vaccine candidates, both the first to undergo human testing in those diseases, turned in some positive early data.
After some nonprofit organizations made noise about the U.S. Army’s plans to license a Zika vaccine to Sanofi, several lawmakers say it’s a bad idea.
This year’s flu vaccine is working for almost half of recipients, the CDC says in an update on what it’s calling a “moderate” season.
NIH has launched a phase 1 trial to test a vaccine that aims to fight a wide range of mosquito-borne diseases.
Sanaria’s malaria vaccine posted more positive clinical data, but a notable gap compared with results from U.S. studies calls for regimen improvements.